New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
10:08 EDTACMP, URI, TGI, TRV, PGEM, PXD, MC, HIMX, FIO, DPZ, COV, CRH, BRCM, BAH, BBVA, AVAV, WSTCOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Access Midstream (ACMP) downgraded to Neutral from Buy at Ladenburg... AeroVironment (AVAV) downgraded to Hold from Buy at Benchmark Co.... Banco Bilbao (BBVA) downgraded to Equal Weight from Overweight at Barclays... Booz Allen (BAH) downgraded to Underperform from Buy at BofA/Merrill... Broadcom (BRCM) downgraded to Hold from Buy at Benchmark Co.... CRH Plc. (CRH) downgraded to Neutral from Outperform at Exane BNP Paribas... Covidien (COV) downgraded to Market Perform from Outperform at BMO Capital... Domino's Pizza (DPZ) downgraded to Underperform from Neutral at BofA/Merrill... Fusion-io (FIO) downgraded to Hold from Buy at Needham... Himax (HIMX) downgraded to Sell from Neutral at UBS... Moelis (MC) downgraded to Neutral from Buy at UBS... Pioneer Natural (PXD) downgraded to Accumulate from Buy at Global Hunter... Ply Gem (PGEM) downgraded to Sell from Neutral at Goldman... Travelers (TRV) downgraded at BMO Capital... Triumph Group (TGI) downgraded to Underperform from Neutral at BofA/Merrill... United Rentals (URI) downgraded to Neutral from Buy at Longbow... West Corp. (WSTC) downgraded to Equal Weight from Overweight at Morgan Stanley.
News For ACMP;AVAV;BBVA;BAH;BRCM;CRH;COV;DPZ;FIO;HIMX;MC;PXD;PGEM;TRV;TGI;URI;WSTC From The Last 14 Days
Check below for free stories on ACMP;AVAV;BBVA;BAH;BRCM;CRH;COV;DPZ;FIO;HIMX;MC;PXD;PGEM;TRV;TGI;URI;WSTC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 28, 2014
15:03 EDTBRCMCSR a potential target for TI, Broadcom after spurning Microchip, Bloomberg says
Subscribe for More Information
07:34 EDTCRHCRH Plc. upgraded to Outperform from Underperform at Credit Suisse
Subscribe for More Information
07:05 EDTCOVCovidien acquires Sapheon, terms not disclosed
Covidien announced that it has acquired Sapheon, Inc., a privately-held developer of venous disease treatments. Financial terms of the transaction were not disclosed.
07:01 EDTCRHCRH Plc. upgraded to Outperform from Underperform at Credit Suisse
August 27, 2014
09:53 EDTPXDOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:06 EDTBRCMBroadcom volatility at record lows
Subscribe for More Information
08:00 EDTPXDPioneer Natural, Laredo Petroleum downgraded at Canaccord
Subscribe for More Information
07:43 EDTBRCMJefferies to hold a summit
Subscribe for More Information
06:46 EDTTGITriumph Group removed from short-term buy list at Deutsche Bank
06:10 EDTPXDPioneer Natural downgraded to Hold from Buy at Canaccord
Subscribe for More Information
August 26, 2014
19:33 EDTCOVCovidien shareholder sues to block sale to Medtronic, Bloomberg reports
Subscribe for More Information
09:41 EDTHIMXHimax awarded USPTO patent for processing 3D stereoscopic image
Reference Link
August 24, 2014
21:56 EDTBRCMB. Riley to hold a tour
Silicon Valley Tech Tour travels throughout Silicon Valley on August 25-27.
August 22, 2014
07:01 EDTCOVCovidien acquires Reverse Medical, terms not disclosed
Subscribe for More Information
August 21, 2014
10:14 EDTCRHOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:51 EDTCRHCRH Plc. upgraded to Market Perform from Underperform at Bernstein
Subscribe for More Information
August 20, 2014
07:18 EDTCOVMedtronic shares have upside with or without deal, says Deutsche Bank
Deutsche Bank sees limited downside risk and significant upside potential for shares of Medtronic (MDT), with or without the pending Covidien (COV) acquisition. Deutsche says the Q1 results show improving trends and it keeps a Buy rating on Medtronic with an $85 price target.
August 19, 2014
08:22 EDTCOVMedtronic: We will continue to pay significant US taxes following Covidien deal
Subscribe for More Information
August 18, 2014
16:10 EDTCOVCovidien says study shows directional atherectomy safe, effective
Covidien announced that directional atherectomy is "safe and effective as a frontline therapy for the treatment of peripheral arterial disease," according to a Covidien study published online today in the Journal of American College of Cardiology, Cardiovascular Interventions. Results from the DEFINITIVE LE study using Covidienís TurboHawk and/or SilverHawk directional atherectomy systems demonstrated 95% limb salvage in patients with critical limb ischemia and 78% overall patency in claudicant patients at 12 months.
08:19 EDTHIMXHimax, Lumus collaborate on next-generation smart glasses development
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use